1-6 of 6
Antonio Molinés
Close
Sort by
Journal Articles

Characteristics, Treatment and Outcome of 15 to 18 Years-Old Adolescents with Chronic Myeloid Leukemia (CML): The Experience of the International Registry of Childhood CML (I-CML-Ped Study)

Morgane Froment, Meinolf Suttorp, Stéphanie Ragot, Hélène Deutsch, Violaine Goyeau, Barbara De Moerloose, Silvia Regina Brandalise, Marina Borisevich, Petr Sedlacek, Adalet Meral Gunes, Birgitte Lausen, Antonio Molines Honrubia, Gordana Jakovljevic, Birgitta Versluys, Krzysztof Kalwak, Andrea Hraskova, Frederic Millot
Journal: Blood
Blood (2021) 138 (Supplement 1): 3602.
https://doi.org/10.1182/blood-2021-150438
Published: 2021
Journal Articles

Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations

Clinical Trials & Observations
Maria Castella, Roser Pujol, Elsa Callén, Juan P. Trujillo, José A. Casado, Hans Gille, Francis P. Lach, Arleen D. Auerbach, Detlev Schindler, Javier Benítez, Beatriz Porto, Teresa Ferro, Arturo Muñoz, Julián Sevilla, Luis Madero, Elena Cela, Cristina Beléndez, Cristina Díaz de Heredia, Teresa Olivé, José Sánchez de Toledo, Isabel Badell, Montserrat Torrent, Jesús Estella, Ángeles Dasí, Antonia Rodríguez-Villa, Pedro Gómez, José Barbot, María Tapia, Antonio Molinés, Ángela Figuera, Juan A. Bueren, Jordi Surrallés
Journal: Blood
Blood (2011) 117 (14): 3759–3769.
https://doi.org/10.1182/blood-2010-08-299917
Published: 2011
Includes: Supplemental data
Journal Articles

Results of PETHEMA LAL-BR-01 Protocol for Low-Risk (LR) Acute Lymphoblastic Leukemia (ALL) In Children

Josep-Maria Ribera, MD, PhD, Albert Oriol, MD, Mireia Morgades, PhD, Pilar Bastida, MD, Olga Garcia, PhD, Alvaro Lasaletta, MD, Jose-Luis Fuster, MD, Elvira Gonzalez-Valentin, MD, Inmaculada Soto, MD, Ana Carbone, MD, Antonio Molines, MD, Izaskun Egurbide, MD, Andres Llorente, MD, Esmeralda Benitez, MD, Luis Madero, MD, PhD, Jose Sanchez de Toledo, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4334.
https://doi.org/10.1182/blood.V116.21.4334.4334
Published: 2010
Journal Articles

One Year Reinductions with Vincristine, Asparaginase and Prednisone as Post-Remission Therapy Improves Outcome in Children with Intermediate Risk (IR) Acute Lymphoblastic Leukemia (ALL).

Albert Oriol, MD, Pilar Bastida, MD, Olga García, Carlota Calvo, Juan-Manuel Perez-Hurtado, Maria-Elvira González Valentin, Jose Luis Fuster, MD, Izaskun Egurbide, Victoria Martin-Reina, Antonio Molines, MD, Javier Lassaletta, Miguel-Angel Sanz, Mar Tormo, Mercedes Carnero, Juan-José Ortega, Josep-Maria Ribera, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2026.
https://doi.org/10.1182/blood.V114.22.2026.2026
Published: 2009
Journal Articles

Treatment with All- Trans Retinoic Acid and Anthracycline Monochemotherapy in Children with Acute Promyelocytic Leukemia: Analysis of Three Sequential Multicenter Trials of the PETHEMA Group

Luis Madero, Pau Montesinos, MD, Pilar Bastida, MD, Amparo Verdeguer, MD, Javier De la Serna, MD, Antonio Molines, MD, Purificacion Garcia, MD, Jose Luis Fuster, MD, Maria jose Allegue, MD, Rafael Rojas, MD, Miguel A. Sanz, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 137.
https://doi.org/10.1182/blood.V112.11.137.137
Published: 2008
Journal Articles

Comparison of Intensive Chemotherapy (CHT), Allogeneic (ALLO) or Autologous (AUTO) Stem Cell Transplantation (SCT) as Post-Remission Treatment for Children with Very High-Risk Acute Lymphoblastic Leukemia (VHR-ALL). Final Results of the PETHEMA ALL-93 Trial.

Josep-Maria Ribera, PhD, Juan-Jose Ortega, MD, Albert Oriol, MD, Pilar Bastida, MD, Carlota Calvo, MD, Jose-María Perez-Hurtado, MD, Maria-Elvira González-Valentin, MD, Vicky Martin-Reina, MD, Antonio Molines, MD, Fernando Ortega-Rivas, MD, Maria-Pilar Queipo, MD, Concepción Rivas, MD, Izaskun Egurbide, MD, Inmaculada Heras, MD, Concepción Poderos, MD, Eva Martínez-Revuelta, MD, Jose-Maria Guinea, MD, Eloy del Potro, MD, Guillermo Deben, MD
Journal: Blood
Blood (2005) 106 (11): 173.
https://doi.org/10.1182/blood.V106.11.173.173
Published: 2005